Avantor, Inc. (AVTR)
14.66
+0.46
(+3.20%)
USD |
NYSE |
Sep 02, 16:00
14.66
0.00 (0.00%)
After-Hours: 19:41
Avantor Research and Development Expense (Annual)
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Medpace Holdings, Inc. | -- |
| Champions Oncology, Inc. | 9.084M |
| Personalis, Inc. | 50.26M |
| Adaptive Biotechnologies Corp. | 83.81M |
| 10X Genomics, Inc. | 238.63M |